Transcatheter aortic valve implantation versus surgical aortic valve replacement: Meta-analysis of clinical outcomes and cost-effectiveness

Current Pharmaceutical Design

Volumn 22, Issue 13, 2016, Pages 1965-1977

  Cao, Christopher ^a,b   Liou, Kevin P ^b   Pathan, Faraz K ^b   Virk, Sohaib ^a   McMonnies, Robert ^a   Wolfenden, Hugh ^b   Indraratna, Praveen ^a  

^a MACQUARIE UNIVERSITY   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Aortic valve replacement; Meta analysis; Systematic review; TAVI; Transcatheter aortic valve implantation

Indexed keywords

ACUTE KIDNEY FAILURE; AORTA VALVE REPLACEMENT; ARTIFICIAL HEART PACEMAKER; BIBLIOGRAPHIC DATABASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; COST EFFECTIVENESS ANALYSIS; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STANDARDIZATION; SYSTEMATIC REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; COST BENEFIT ANALYSIS; ECONOMICS; HEART VALVE REPLACEMENT;

COST-BENEFIT ANALYSIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84964270193     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612822666160219120713     Document Type: Review

References (50)

1. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease pathogenesis, disease progression, and treatment strategies. Circulation 2005; 111(24): 3316-26.
2. Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J 1988; 9(suppl E): 57-64.
3. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis first human case description. Circulation 2002; 106(24): 3006-08.
4. Mylotte D, Osnabrugge RL, Windecker S, et al. Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization. J Am Coll Cardiol 2013; 62(3): 210-19.
5. Anderson JL, Heidenreich PA, Barnett PG, et al. ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63(21): 2304-22.
6. Anderson JL HP, Barnett PG, Creager MA, et al. Acc/aha statement on cost/value methodology in clinical practice guidelines and performance measures: A report of the american college of cardiology/american heart association task force on performance measures and task force on practice guidelines. Circulation 2014; 129: 2329-45.
7. Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document†. J Am Coll Cardiol 2012; 60(15): 1438-54.
8. Shaw LJ, Eisenstein EL, Hachamovitch R, Heller GV, Miller DD. A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part II. J Nuclear Cardiol 1997; 4(1): 52-60.
9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7(3): 177-88.
10. Higgins JP TS. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21(11): 1539-58.
11. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aorticvalve replacement with a self-expanding prosthesis. New Engl J Med 2014; 370(19): 1790-98.
12. Appel C-F, Hultkvist H, Nylander E, et al. Transcatheter versus surgical treatment for aortic stenosis: Patient selection and early outcome. Scand Cardiovasc J 2012; 46(5): 301-7.
13. Clavel M, Webb J, Rodés-Cabau J, et al. Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation 2010; 122(19): 1928-36.
14. Conradi L, Seiffert M, Treede H, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement: a propensity score analysis in patients at high surgical risk. J Thoracic Cardiovas Surg 2012; 143(1): 64-71.
15. De Carlo M, Giannini C, Ettori F, et al. Impact of treatment choice on the outcome of patients proposed for transcatheter aortic valve implantation. EuroIntervention 2010; 6(5): 568-74.
16. D'Errigo P, Barbanti M, Ranucci M, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: Results from an intermediate risk propensitymatched population of the Italian OBSERVANT study. Int J Cardiol 2013; 167(5): 1945-52.
17. D'Onofrio A, Rizzoli G, Messina A, et al. Conventional surgery, sutureless valves, and transapical aortic valve replacement: What is the best option for patients with aortic valve stenosis? A multicenter, propensity-matched analysis. J Thorac Cardiovasc Surg 2013; 146(5): 1065-71.
18. Dubois C, Coosemans M, Rega F, et al. Prospective evaluation of clinical outcomes in all-comer high-risk patients with aortic valve stenosis undergoing medical treatment, transcatheter or surgical aortic valve implantation following heart team assessment. Interactive Cardiovasc Thorac Surg 2013: ivt228.
19. Dvir D, Sagie A, Porat E, et al. Clinical profile and outcome of patients with severe aortic stenosis at high surgical risk: Singlecenter prospective evaluation according to treatment assignment. Catheterization Cardiovasc Interventions 2013; 81(5): 871-81.
20. Ewe SH, Ajmone Marsan N, Pepi M, et al. Impact of left ventricular systolic function on clinical and echocardiographic outcomes following transcatheter aortic valve implantation for severe aortic stenosis. Am Heart J 2010; 160(6): 1113-20.
21. Fusari M, Bona V, Muratori M, et al. Transcatheter vs. surgical aortic valve replacement: a retrospective analysis assessing clinical effectiveness and safety. J Cardiovas Med 2012; 13(4): 229-41.
22. Holzhey DM, Shi W, Rastan A, Borger MA, Hansig M, Mohr FW. Transapical versus conventional aortic valve replacement—a propensity-matched comparison. Heart Surg Forum 2012; 15(1): E4-8.
23. Knipp SC, Kahlert P, Jokisch D, et al. Cognitive function after transapical aortic valve implantation: a single-centre study with 3-month follow-up. Interactive Cardiovasc Thorac Surg 2013; 16(2): 116-22.
24. Latib A, Maisano F, Bertoldi L, et al. Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: A propensity score–matched case-control study. Am Heart J 2012; 164(6): 910-17.
25. Nguyen TC, Babaliaros VC, Razavi SA, et al. Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement. J Thorac Cardiovasc Surg 2013; 146(6): 1399-407.
26. Nielsen HHM, Klaaborg KE, Nissen H, et al. A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial. EuroIntervention 2012; 8(3): 383-9.
27. Piazza N, Kalesan B, van Mieghem N, et al. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients. JACC: Cardiovasc Intervent 2013; 6(5): 443-51.
28. Santarpino G, Pfeiffer S, Jessl J, et al. Sutureless replacement versus transcatheter valve implantation in aortic valve stenosis: A propensity-matched analysis of 2 strategies in high-risk patients. J Thorac Cardiovasc Surg 2014; 147(2): 561-67.
29. Silberman S, Abu AF, Bitran D, et al. Comparison between transcatheter and surgical aortic valve replacement: a single-center experience. J Heart Valve Dis 2013; 22(4): 448-54.
30. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. New Engl J Med 2011; 364(23): 2187-98.
31. Stohr R, Dohmen G, Herpertz R, et al. Thirty-day outcome after transcatheter aortic valve implantation compared with surgical valve replacement in patients with high-risk aortic stenosis: a matched comparison. Coron Artery Dis 2011; 22(8): 595-600.
32. Tamburino C, Barbanti M, Capodanno D, et al. Earlyand midterm outcomes of transcatheter aortic valve implantation in patients with logistic EuroSCORE less than 20%: A comparative analysis between different risk strata. Catheterization Cardiovasc Interventions 2012; 79(1): 132-40.
33. Wenaweser P, Pilgrim T, Kadner A, et al. Clinical outcomes of patients with severe aortic stenosis at increased surgical risk according to treatment modality. J Am Coll Cardiol 2011; 58(21): 2151-62.
34. Zierer A, Wimmer-Greinecker G, Martens S, Moritz A, Doss M. Is transapical aortic valve implantation really less invasive than minimally invasive aortic valve replacement? J Thorac Cardiovasc Surg 2009; 138(5): 1067-72.
35. Fairbairn TA, Meads DM, Hulme C, et al. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk. Heart 2013; 99(13): 914-20.
36. Gada H, Agarwal S, Marwick TH. Perspective on the costeffectiveness of transapical aortic valve implantation in high-risk patients: Outcomes of a decision-analytic model. Ann Cardiothorac Surg 2012; 1(2): 145.
37. Reynolds MR, Magnuson EA, Lei Y, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol 2012; 60(25): 2683-92.
38. Osnabrugge RL, Head SJ, Genders TS, et al. Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients. Ann Thorac Surg 2012; 94(6): 1954-60.
39. Gada H, Kapadia SR, Tuzcu EM, Svensson LG, Marwick TH. Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients. Am J Cardiol 2012; 109(9): 1326-33.
40. Doble B, Blackhouse G, Goeree R, Xie F. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: A Canadian perspective. J Thorac Cardiovasc Surg 2013; 146(1): 52-60. e3.
41. Neyt M, Van Brabandt H, Devriese S, Van De Sande S. A costutility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open 2012; 2(3).
42. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annl Intern Med 2009; 151(4): 264-69.
43. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonaryartery prosthetic conduit with valve dysfunction. Lancet 2000; 356(9239): 1403-5.
44. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. New Engl J Med 2012; 366(18): 1686-95.
45. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. New Engl J Med 2010; 363(17): 1597-607.
46. Van Brabandt H, Neyt M, Hulstaert F. Transcatheter aortic valve implantation (TAVI): risky and costly. BMJ 2012; 345(345): e4710.
47. Binder RK, Rodes-Cabau J, Wood DA, Webb JG. Edwards SAPIEN 3 valve. EuroIntervention 2012; 8: Q83-7.
48. Willson AB, Rodès-Cabau J, Wood DA, et al. Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: first-inhuman experience. J Am Coll Cardiol 2012; 60(7): 581-86.
49. Wijeysundera HC, Wong WW, Bennell MC, et al. Impact of wait times on the effectiveness of transcatheter aortic valve replacement in severe aortic valve disease: a discrete event simulation model. Canadian J Cardiol 2014; 30(10): 1162-69.
50. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012) the joint task force on the management of valvular heart disease of the european society of cardiology (ESC) and the european association for cardio-thoracic surgery (EACTS). Eur Heart J 2012; 33(19): 2451-96.